RUSSIA'S NOVAK SAYS OIL WELLS DRILLING SHOULD BE FINANCED IN ORDER TO RESTART DRILLING ONCE CURBS ARE OVER
RUSSIA'S NOVAK SAYS HIGH OIL STORAGES PLAYS INTO UNCERTAINTY OVER GLOBAL ECONOMIC RECOVERY || SAYS GASOLINE DEMAND IN RUSSIA HAS FALLEN BY 40-50% IN APRIL SO FAR
Markets end at the highest levels since March 13 in trade led by gains in HDFC, HDFC Bank, TCS, ICICI Bank.
INDIA CHIEF ECONOMIC ADVISER: WORKING ON PROVIDING SIGNIFICANT LIQUIDITY, THEREBY TAKING CARE OF CASH FLOW NEEDS
INDIA FARM MINISTER: WHEAT HARVESTING TO BE FULLY COMPLETED BY NEXT WEEK|| WHEAT PROCUREMENT AT 11.7M TONS SO FAR || PULSES, OILSEEDS HARVESTING COMPLETED
INDIA NITI AAYOG MEMBER RAMESH CHAND: AGRI MARKETS INTACT, PRICES HAVE NOT CRASHED || EXPECT FARM SECTOR GROWTH OF AT LEAST 3% THIS FY
GERMAN GOVERNMENT SPOKESWOMAN: WILL BE NO DECISIONS ON STIMULUS MEASURES DURING MERKEL CALL WITH AUTO EXECUTIVES ON MAY 5
SINCE THE LAST 3 DAYS, THE DOUBLING RATE IS 11.3 DAYS IN THE COUNTRY. ALTHOUGH THE GLOBAL MORTALITY RATE IS AROUND 7%, INDIA IS HAVING A MORTALITY RATE OF AROUND 3% & AROUND 86% OF FATALITY OF PERSONS WITH CO-MORBIDITY: DR. HARSH VARDHAN, INDIA MINIS
CORONAVIRUS UPDATE: INDIA - 10 NEW COVID19 CASES HAVE BEEN REPORTED IN KERALA TODAY. THIS INCLUDES 3 HEALTH WORKERS & A JOURNALIST. TOTAL ACTIVE CASES IN THE STATE STAND AT 495 WHICH INCLUDES 123 ACTIVE CASES: KERALA CM PINARAYI VIJAYAN
☀ ONLY 0.33% PATIENTS ARE ON VENTILATORS, 1.5% PATIENTS ARE ON OXYGEN SUPPORT AND 2.34% PATIENTS ARE IN ICU, WHICH REFLECTS THE QUALITY OF CARE BEING PROVIDED ACROSS THE COUNTRY: DR. HARSH VARDHAN, INDIA MINISTER OF HEALTH
✴288 GOVT LABS WORKING ALONG WITH 97 PRIVATE LAB CHAINS WITH AROUND 16,000 SAMPLE COLLECTION CENTRES&TESTING AROUND 60,000 TESTS PER DAY. INDIA GOVT IS WORKING TO INCREASE TESTING CAPACITY TO 1 LAKH TESTS PER DAY WITHIN NEXT FEW DAYS: DR. HARSH VARDHA
Supreme Court has directed the revenue department to release Rs 733 crore in tax refunds to Vodafone Idea, @PayaswiniLLB reports.
GlaxoSmithKline prepares to start a sale of its $3.7 billion stake in Unilever’s listed India unit.
CORONAVIRUS UPDATE: INDIA - WITH 1813 NEW CASES & 71 DEATHS REPORTED IN THE LAST 24 HOURS, THE TOTAL NUMBER OF COVID-19 POSITIVE CASES IN INDIA RISES TO 31787 (INCLUDING 22982 ACTIVE CASES, 1008 DEATHS, 7797 CURED/DISCHARGED AND 1 MIGRATED): INDIA HE
FII BUY NET INR 722.08 CR OF INDIA SHARES TODAY || DII BUY NET INR 78.67 CR
INDIA HOME MINISTRY ISSUES DIRECTIONS ON MOVEMENT OF PERSONS DURING LOCKDOWN || STATES SHOULD DEVELOP PROTOCOLS FOR RECEIVING, SENDING STRANDED MIGRANT WORKERS, TOURISTS AMID LOCKDOWN
Punjab Chief Minister Amarinder Singh announced extension of curfew in the state by two weeks after May 3
Ministry of Home Affairs (MHA) allows movement of migrant workers, tourists, students stranded at various places
U.S. economy shrinks at 4.8% pace, signaling start of recession
CORONAVIRUS UPDATE: INDIA - MUMBAI: DHARAVI REPORTS 14 NEW CASES BRINGING THE TALLY TO 344 CASES INCLUDING 18 DEATHS
FII BUY NET INR 722.08 CR OF INDIA SHARES TODAY || DII BUY NET INR 78.67 CR
☀ GILEAD SCIENCES INC - AWARE OF POSITIVE DATA EMERGING FROM NIAID'S STUDY OF INVESTIGATIONAL ANTIVIRAL REMDESIVIR FOR TREATMENT OF COVID-19
☀GILEAD SCIENCES INC - AWARE OF POSITIVE DATA EMERGING FROM NIAID'S STUDY OF INVESTIGATIONAL ANTIVIRAL REMDESIVIR FOR TREATMENT OF COVID-19
☀GILEAD SCIENCES - SEES DATA AT END OF MAY FROM 2ND SIMPLE STUDY EVALUATING 5- AND 10-DAY DOSING DURATIONS OF REMDESIVIR IN PATIENTS WITH MODERATE COVID-19 DISEASE
☀GILEAD- PATIENTS IN REMDESIVIR TRIAL ACHIEVED CLINICAL RECOVERY IF THEY NO LONGER REQUIRED OXYGEN SUPPORT & MEDICAL CARE
CORONAVIRUS: 445 MORE DEATHS IN ENGLAND - SUN NEWSPAPER
CORONAVIRUS: ENGLAND'S HOSPITAL DEATH TOLL RISES TO 19,746 FROM 19,301 THE PREVIOUS DAY
CORONAVIRUS UPDATE: INDIA - 16 FRESH CASES OF COVID-19 REPORTED IN JAMMU AND KASHMIR, STATE TALLY REACHES 581: OFFICIALS
CORONAVIRUS: ENGLAND'S HOSPITAL DEATH TOLL RISES TO 19,746 FROM 19,301 THE PREVIOUS DAY
Gilead Sciences Inc.’s experimental drug to treat coronavirus helped patients recover faster than standard care, the company said, offering hope for what could be the first effective treatment for the illness that has swept the world.
A trial being run by the U.S.’s National Institute of Allergy and Infectious Diseases looked at whether Gilead’s remdesivir helped people with Covid-19 recover faster than without it.
These study results complement data from the *placebo- controlled study* of remdesivir conducted by the National Institute for Allergy and Infectious Diseases and help to determine the optimal duration of treatment with remdesivir
We feel *placebo- controlled study* the study by National Institute of Allergy and Infectious Diseases will help to get FDA approval faster. Positive
0 Comments